Steroids vs peptides: what TikTok gets wrong about the tradeoffs

What did @unclesteventt actually say?

Honestly? Not much. The transcript from this video is nearly incoherent. There are no specific claims about steroids, peptides, Mounjaro, or testosterone anywhere in what was actually said. The creator appears to speak about immigration, personal hardship, and working hard, then closes with a standard "like and subscribe" call to action.

The hashtags promise a comparison of steroids versus peptides, with references to bodybuilding and weight loss. The caption name-drops Mounjaro and testosterone. But the transcript delivers none of that. What we have is a mismatch between the video's marketed framing and its actual content, which is a pattern worth flagging for anyone relying on TikTok for health information.

Without substantive health claims in the transcript, this fact-check focuses on what the hashtags and caption imply, and what the science actually says about those topics.

Does the science back this up?

There is no health claim in this transcript to evaluate directly. But the implied comparison between anabolic steroids and peptides is a real topic circulating in fitness communities, so it deserves honest treatment.

Anabolic-androgenic steroids (AAS) like testosterone have a well-documented pharmacological profile. They bind androgen receptors and drive protein synthesis, but they come with a serious adverse-effect burden including cardiovascular remodeling, suppression of endogenous hormone production, and hepatotoxicity with oral forms (Hartgens and Kuipers, 2004, Sports Medicine). Peptides are a much broader category. Growth hormone secretagogues like CJC-1295 and ipamorelin stimulate pulsatile GH release rather than replacing it directly, which is mechanistically different from exogenous testosterone. Research on most therapeutic peptides remains limited to animal models or small human trials. BPC-157, for instance, shows promising tissue-repair effects in rodent studies (Sikiric et al., 2018, Current Pharmaceutical Design), but human randomized controlled trial data is thin. Anyone comparing steroids and peptides as if they are interchangeable tools is oversimplifying substantially.

What did they get wrong (or right)?

Since the creator made no checkable health claims, there is nothing technically wrong from a clinical accuracy standpoint. That is almost the problem. A video tagged with Mounjaro, testosterone, and bodybuilding that delivers zero substantive information is not harmless. It uses high-credibility health hashtags to attract a health-curious audience and then provides nothing of value.

Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes and, as Zepbound, for chronic weight management. It is not a peptide in the therapeutic optimization sense that fitness communities use that word. Lumping it into a steroids-versus-peptides frame alongside bodybuilding hashtags is misleading by association, even if nothing explicit was said. The creator gets no credit here for accuracy because there was no accuracy to evaluate, and no demerits for specific misinformation either. The problem is the gap between what was promised and what was delivered.

What should you actually know?

If you landed on this video looking for a real comparison of anabolic steroids and peptide therapies, here is a faster summary than the video provided. These are not equivalent categories. Testosterone replacement therapy (TRT) at physiological doses is FDA-approved and has a large clinical evidence base. Supraphysiologic anabolic steroid use is a different risk profile entirely. Peptides like ipamorelin or CJC-1295 are not FDA-approved for bodybuilding or anti-aging use, and most are only available through compounding pharmacies, which means quality and dosing consistency vary. Comparing them to steroids or to brand-name GLP-1 drugs like Mounjaro as if they occupy the same regulatory or evidence tier is inaccurate.

Anyone considering peptide therapy should be working with a licensed clinician who can review their hormone panels, metabolic markers, and goals, not making decisions based on hashtag-driven TikTok content. Platforms like FormBlends exist precisely because this kind of context-free health content is everywhere, and sorting signal from noise requires actual clinical oversight.